This Spine session was recorded live at the 2025 AANS Annual Scientific Meeting.

Using data from the QOD, outcomes to surgeries with long-term follow up data are discussed and presented. Learn the most up to date information and outcomes data from rigorously acquired and analyzed data.

Speakers: Ranbir Ahluwalia, Erica Bisson, Mohamad Bydon, Andrew Chan, Kevin Foley, Kai-Ming Fu, Harsh Jain, John Knightly, Vik Kohli, David Kurland, Paul Park, Peter Passias, Danyal Quraishi

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The last date to claim credit is 06/30/2028.

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Those who have disclosed a relationship with ineligible companies are listed below.

All disclosed financial relationships have been mitigated in accordance with ACCME standards.

Name	Relationship/Company
Erica Bisson	Stryker: Consultant (Ongoing); MiRus: Consultant (Ongoing), Ownership Interest (Ongoing); NView: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); ProprioVision: Advisor (Ongoing), Stock Options (Ongoing); See All ai: Ownership Interest (Ongoing)
Andrew Chan	Alphatec Spine: Consultant (Ongoing); Cervical Spine Research Society: Grant/Research Support (Ongoing); Isto Biologics: Consultant (Ongoing); SpineArt: Speaker/Honoraria (Ongoing)
Kevin Foley	Accelus: Stock Shareholder (excluding mutual funds) (Ongoing); Discgenics: Board Member/Officer/Trustee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); DuraStat: Board Member/Officer/Trustee (Ongoing), Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Medtronic: Consultant (Ongoing), Royalty Recipient (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); RevBio: Board Member/Officer/Trustee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); True Digital Surgery: Board Member/Officer/Trustee (Ongoing), Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Vori Health: Stock Shareholder (excluding mutual funds) (Ongoing)

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.